Global Dry Age-Related Macular Degeneration Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dry Age-Related Macular Degeneration Market Size 2017-2028

2.1.2 Dry Age-Related Macular Degeneration Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Dry Age-Related Macular Degeneration Segment by Type

2.2.1 Oral

2.2.2 Injectables

2.3 Dry Age-Related Macular Degeneration Market Size by Type

2.3.1 Dry Age-Related Macular Degeneration Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2017-2022)

2.4 Dry Age-Related Macular Degeneration Segment by Application

2.4.1 Above 40 Years

2.4.2 Above 60 Years

2.4.3 Above 75 Years

2.5 Dry Age-Related Macular Degeneration Market Size by Application

2.5.1 Dry Age-Related Macular Degeneration Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Application (2017-2022)

3 Dry Age-Related Macular Degeneration Market Size by Player

3.1 Dry Age-Related Macular Degeneration Market Size Market Share by Players

3.1.1 Global Dry Age-Related Macular Degeneration Revenue by Players (2020-2022)

3.1.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Players (2020-2022)

3.2 Global Dry Age-Related Macular Degeneration Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Dry Age-Related Macular Degeneration by Regions

4.1 Dry Age-Related Macular Degeneration Market Size by Regions (2017-2022)

4.2 Americas Dry Age-Related Macular Degeneration Market Size Growth (2017-2022)

4.3 APAC Dry Age-Related Macular Degeneration Market Size Growth (2017-2022)

4.4 Europe Dry Age-Related Macular Degeneration Market Size Growth (2017-2022)

4.5 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth (2017-2022)

5 Americas

5.1 Americas Dry Age-Related Macular Degeneration Market Size by Country (2017-2022)

5.2 Americas Dry Age-Related Macular Degeneration Market Size by Type (2017-2022)

5.3 Americas Dry Age-Related Macular Degeneration Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dry Age-Related Macular Degeneration Market Size by Region (2017-2022)

6.2 APAC Dry Age-Related Macular Degeneration Market Size by Type (2017-2022)

6.3 APAC Dry Age-Related Macular Degeneration Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Dry Age-Related Macular Degeneration by Country (2017-2022)

7.2 Europe Dry Age-Related Macular Degeneration Market Size by Type (2017-2022)

7.3 Europe Dry Age-Related Macular Degeneration Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dry Age-Related Macular Degeneration by Region (2017-2022)

8.2 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Type (2017-2022)

8.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Dry Age-Related Macular Degeneration Market Forecast

10.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2023-2028)

10.1.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2023-2028)

10.1.2 Americas Dry Age-Related Macular Degeneration Forecast

10.1.3 APAC Dry Age-Related Macular Degeneration Forecast

10.1.4 Europe Dry Age-Related Macular Degeneration Forecast

10.1.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast

10.2 Americas Dry Age-Related Macular Degeneration Forecast by Country (2023-2028)

10.2.1 United States Dry Age-Related Macular Degeneration Market Forecast

10.2.2 Canada Dry Age-Related Macular Degeneration Market Forecast

10.2.3 Mexico Dry Age-Related Macular Degeneration Market Forecast

10.2.4 Brazil Dry Age-Related Macular Degeneration Market Forecast

10.3 APAC Dry Age-Related Macular Degeneration Forecast by Region (2023-2028)

10.3.1 China Dry Age-Related Macular Degeneration Market Forecast

10.3.2 Japan Dry Age-Related Macular Degeneration Market Forecast

10.3.3 Korea Dry Age-Related Macular Degeneration Market Forecast

10.3.4 Southeast Asia Dry Age-Related Macular Degeneration Market Forecast

10.3.5 India Dry Age-Related Macular Degeneration Market Forecast

10.3.6 Australia Dry Age-Related Macular Degeneration Market Forecast

10.4 Europe Dry Age-Related Macular Degeneration Forecast by Country (2023-2028)

10.4.1 Germany Dry Age-Related Macular Degeneration Market Forecast

10.4.2 France Dry Age-Related Macular Degeneration Market Forecast

10.4.3 UK Dry Age-Related Macular Degeneration Market Forecast

10.4.4 Italy Dry Age-Related Macular Degeneration Market Forecast

10.4.5 Russia Dry Age-Related Macular Degeneration Market Forecast

10.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast by Region (2023-2028)

10.5.1 Egypt Dry Age-Related Macular Degeneration Market Forecast

10.5.2 South Africa Dry Age-Related Macular Degeneration Market Forecast

10.5.3 Israel Dry Age-Related Macular Degeneration Market Forecast

10.5.4 Turkey Dry Age-Related Macular Degeneration Market Forecast

10.5.5 GCC Countries Dry Age-Related Macular Degeneration Market Forecast

10.6 Global Dry Age-Related Macular Degeneration Forecast by Type (2023-2028)

10.7 Global Dry Age-Related Macular Degeneration Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Santen Pharmaceuticals

11.1.1 Santen Pharmaceuticals Company Information

11.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered

11.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Santen Pharmaceuticals Main Business Overview

11.1.5 Santen Pharmaceuticals Latest Developments

11.2 Allergan

11.2.1 Allergan Company Information

11.2.2 Allergan Dry Age-Related Macular Degeneration Product Offered

11.2.3 Allergan Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Allergan Main Business Overview

11.2.5 Allergan Latest Developments

11.3 Bausch Health

11.3.1 Bausch Health Company Information

11.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Offered

11.3.3 Bausch Health Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Bausch Health Main Business Overview

11.3.5 Bausch Health Latest Developments

11.4 Alimera Science

11.4.1 Alimera Science Company Information

11.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Offered

11.4.3 Alimera Science Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Alimera Science Main Business Overview

11.4.5 Alimera Science Latest Developments

11.5 Phio Pharmaceuticals

11.5.1 Phio Pharmaceuticals Company Information

11.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered

11.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Phio Pharmaceuticals Main Business Overview

11.5.5 Phio Pharmaceuticals Latest Developments

11.6 Ocumension Therapeutics

11.6.1 Ocumension Therapeutics Company Information

11.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Offered

11.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Ocumension Therapeutics Main Business Overview

11.6.5 Ocumension Therapeutics Latest Developments

11.7 Belite Bio

11.7.1 Belite Bio Company Information

11.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Offered

11.7.3 Belite Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Belite Bio Main Business Overview

11.7.5 Belite Bio Latest Developments

11.8 Kubota Vision

11.8.1 Kubota Vision Company Information

11.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Offered

11.8.3 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Kubota Vision Main Business Overview

11.8.5 Kubota Vision Latest Developments

11.9 Iveric Bio

11.9.1 Iveric Bio Company Information

11.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Offered

11.9.3 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Iveric Bio Main Business Overview

11.9.5 Iveric Bio Latest Developments

11.10 Eyestem Research

11.10.1 Eyestem Research Company Information

11.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Offered

11.10.3 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Eyestem Research Main Business Overview

11.10.5 Eyestem Research Latest Developments

11.11 Y2 Solution

11.11.1 Y2 Solution Company Information

11.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Offered

11.11.3 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Y2 Solution Main Business Overview

11.11.5 Y2 Solution Latest Developments

11.12 Stealth Biotherapeutics

11.12.1 Stealth Biotherapeutics Company Information

11.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Offered

11.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Stealth Biotherapeutics Main Business Overview

11.12.5 Stealth Biotherapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. Dry Age-Related Macular Degeneration Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Oral

Table 3. Major Players of Injectables

Table 4. Dry Age-Related Macular Degeneration Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Dry Age-Related Macular Degeneration Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2017-2022)

Table 7. Dry Age-Related Macular Degeneration Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Dry Age-Related Macular Degeneration Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Dry Age-Related Macular Degeneration Market Size Market Share by Application (2017-2022)

Table 10. Global Dry Age-Related Macular Degeneration Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Dry Age-Related Macular Degeneration Revenue Market Share by Player (2020-2022)

Table 12. Dry Age-Related Macular Degeneration Key Players Head office and Products Offered

Table 13. Dry Age-Related Macular Degeneration Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Dry Age-Related Macular Degeneration Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Dry Age-Related Macular Degeneration Market Size Market Share by Regions (2017-2022)

Table 18. Americas Dry Age-Related Macular Degeneration Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Country (2017-2022)

Table 20. Americas Dry Age-Related Macular Degeneration Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Type (2017-2022)

Table 22. Americas Dry Age-Related Macular Degeneration Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Application (2017-2022)

Table 24. APAC Dry Age-Related Macular Degeneration Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Region (2017-2022)

Table 26. APAC Dry Age-Related Macular Degeneration Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Type (2017-2022)

Table 28. APAC Dry Age-Related Macular Degeneration Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Application (2017-2022)

Table 30. Europe Dry Age-Related Macular Degeneration Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Country (2017-2022)

Table 32. Europe Dry Age-Related Macular Degeneration Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Type (2017-2022)

Table 34. Europe Dry Age-Related Macular Degeneration Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Dry Age-Related Macular Degeneration

Table 43. Key Market Challenges & Risks of Dry Age-Related Macular Degeneration

Table 44. Key Industry Trends of Dry Age-Related Macular Degeneration

Table 45. Global Dry Age-Related Macular Degeneration Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Dry Age-Related Macular Degeneration Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Application (2023-2028)

Table 51. Santen Pharmaceuticals Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 52. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered

Table 53. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Santen Pharmaceuticals Main Business

Table 55. Santen Pharmaceuticals Latest Developments

Table 56. Allergan Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 57. Allergan Dry Age-Related Macular Degeneration Product Offered

Table 58. Allergan Main Business

Table 59. Allergan Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Allergan Latest Developments

Table 61. Bausch Health Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 62. Bausch Health Dry Age-Related Macular Degeneration Product Offered

Table 63. Bausch Health Main Business

Table 64. Bausch Health Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Bausch Health Latest Developments

Table 66. Alimera Science Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 67. Alimera Science Dry Age-Related Macular Degeneration Product Offered

Table 68. Alimera Science Main Business

Table 69. Alimera Science Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Alimera Science Latest Developments

Table 71. Phio Pharmaceuticals Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 72. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered

Table 73. Phio Pharmaceuticals Main Business

Table 74. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Phio Pharmaceuticals Latest Developments

Table 76. Ocumension Therapeutics Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 77. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Offered

Table 78. Ocumension Therapeutics Main Business

Table 79. Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Ocumension Therapeutics Latest Developments

Table 81. Belite Bio Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 82. Belite Bio Dry Age-Related Macular Degeneration Product Offered

Table 83. Belite Bio Main Business

Table 84. Belite Bio Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Belite Bio Latest Developments

Table 86. Kubota Vision Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 87. Kubota Vision Dry Age-Related Macular Degeneration Product Offered

Table 88. Kubota Vision Main Business

Table 89. Kubota Vision Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Kubota Vision Latest Developments

Table 91. Iveric Bio Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 92. Iveric Bio Dry Age-Related Macular Degeneration Product Offered

Table 93. Iveric Bio Main Business

Table 94. Iveric Bio Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Iveric Bio Latest Developments

Table 96. Eyestem Research Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 97. Eyestem Research Dry Age-Related Macular Degeneration Product Offered

Table 98. Eyestem Research Main Business

Table 99. Eyestem Research Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Eyestem Research Latest Developments

Table 101. Y2 Solution Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 102. Y2 Solution Dry Age-Related Macular Degeneration Product Offered

Table 103. Y2 Solution Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Y2 Solution Main Business

Table 105. Y2 Solution Latest Developments

Table 106. Stealth Biotherapeutics Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors

Table 107. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Offered

Table 108. Stealth Biotherapeutics Main Business

Table 109. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Stealth Biotherapeutics Latest Developments

List of Figures

Figure 1. Dry Age-Related Macular Degeneration Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Dry Age-Related Macular Degeneration Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Dry Age-Related Macular Degeneration Market Size Market Share by Type in 2021

Figure 7. Dry Age-Related Macular Degeneration in Above 40 Years

Figure 8. Global Dry Age-Related Macular Degeneration Market: Above 40 Years (2017-2022) & ($ Millions)

Figure 9. Dry Age-Related Macular Degeneration in Above 60 Years

Figure 10. Global Dry Age-Related Macular Degeneration Market: Above 60 Years (2017-2022) & ($ Millions)

Figure 11. Dry Age-Related Macular Degeneration in Above 75 Years

Figure 12. Global Dry Age-Related Macular Degeneration Market: Above 75 Years (2017-2022) & ($ Millions)

Figure 13. Global Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2021

Figure 14. Global Dry Age-Related Macular Degeneration Revenue Market Share by Player in 2021

Figure 15. Global Dry Age-Related Macular Degeneration Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Dry Age-Related Macular Degeneration Market Size 2017-2022 ($ Millions)

Figure 17. APAC Dry Age-Related Macular Degeneration Market Size 2017-2022 ($ Millions)

Figure 18. Europe Dry Age-Related Macular Degeneration Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Dry Age-Related Macular Degeneration Market Size 2017-2022 ($ Millions)

Figure 20. Americas Dry Age-Related Macular Degeneration Value Market Share by Country in 2021

Figure 21. Americas Dry Age-Related Macular Degeneration Consumption Market Share by Type in 2021

Figure 22. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2021

Figure 23. United States Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Region in 2021

Figure 28. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2021

Figure 29. China Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Country in 2021

Figure 36. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Type in 2021

Figure 37. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2021

Figure 38. Germany Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2021

Figure 46. Egypt Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Dry Age-Related Macular Degeneration Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 52. APAC Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 53. Europe Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 55. United States Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 56. Canada Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 59. China Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 60. Japan Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 61. Korea Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 63. India Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 64. Australia Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 65. Germany Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 66. France Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 67. UK Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 68. Italy Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 69. Russia Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 70. Spain Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 73. Israel Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Dry Age-Related Macular Degeneration Market Size 2023-2028 ($ Millions)